Heparin therapy in routine hemodialysis
Pittard, J.D.
Nephrology News and Issues 15(5): 73-75
2001
ISSN/ISBN: 0896-1263 PMID: 12108969 Document Number: 534808
Document emailed within 1 workday
Related Documents
Pelayo Alonso, R.; Cobo Sánchez, J.L.; de Buruaga Perea, A.S.áe.; Menezo Viadero, R.; Gándara Revuelta, M.; Aja Crespo, A.; Tovar Rincón, A. 2013: Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems Revista de Enfermeria 36(3): 8-12Romão Júnior, J.E.; Fadil, M.A.; Zeratti, A.D.; Sabbaga, E. 1983: Hemodialysis without heparin Revista do Hospital das Clinicas 38(2): 70-72
Zimmermann, R.E.; Schwering, H.; Wittrin, G.; Hollenders, T. 1981: Control of low-dose heparin therapy using photometry to detect biologically active heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(5): 316-319
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Heine, H. 1983: Transcutaneous heparin therapy. Experimental histological studies with the effective combination heparin--allantoin--D panthenol Die Medizinische Welt 34(20): 602-604
Buccianti, G.; Pogliani, E.; Lorenz, M.; Cofrancesco, E.; Bianchi, M.L.; Cresseri, D.; Valenti, G. 1985: Heparin dosage during hemodialysis Journal of Laboratory and Clinical Medicine 105(1): 139-140
Simons, O. 1984: Heparin activity during hemodialysis Clinical Nephrology 21(4): 247
Janczak, D.; Pupka, A.; Skóra, J.; Szyber, P.ła.; Czapla, B.ło. 2010: The use of the heparin-bonded ePTFE grafts for needs of the hemodialysis Polimery W Medycynie 40(4): 35-39
Tanchev, I.; Genov, K.; Kurlova, E.; Stavreva, E.; Tancheva, D. 1982: Treatment of chronic renal failure by means of routine hemodialysis Vutreshni Bolesti 21(3): 53-61
Pristautz, H.; Katschnig, H.; Schenk, H.; Steinberger, R.; Pogglitsch, H.; Sailer, S. 1979: Effect of various parameters on heparin utilization in short-term hemodialysis Die Medizinische Welt 30(49): 1846-1848
Henríquez, F.; Rodríguez, A.; Mora, C.; Sánchez-Deig, E.; Macía, M.; Navarro, J. 2006: Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 26(6): 734-737
Gavranić, B.B.; Basić-Jukić, N.; Kes, P. 2012: Patient who developed heparin-induced thrombocytopenia type Ii after 24 years on hemodialysis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 66(Suppl 2): 68-71
Buccianti, G.; Valenti, G.; Lorenz, M.; Cresseri, D.; Strada, E.; Nazzari, M. 1990: Kinetics of anti-Xa activity during combined defibrotide-heparin administration in hemodialysis International Journal of Artificial Organs 13(7): 416-420
Matsuo, T.; Matsuo, M.; Ouga-Maruyama, S. 2001: Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)? Thrombosis and Haemostasis 86(4): 1115-1116
Benítez, M.; González Gómez, I.; González Carmelo, I.; Palma, A.; Cruz, S.; Rodríguez, E.; Amián, A.; Fernández M, F.; Merino, M.J.; Fernández G, F.; Suárez, C.; Onaindía, J.M.; González, J. 2007: Heparin immune thrombocytopenia in a hemodialysis patient. A case report. Literature review Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(6): 756-760
Eastwood, J.B.; Phillips, M.E.; Minty, P.; Gower, P.E.; Curtis, J.R. 1983: Heparin inactivation, acidosis and copper poisoning due to presumed acid contamination of water in a hemodialysis unit Clinical Nephrology 20(4): 197-201
Leu, J.G.; Liou, H.H.; Wu, S.C.; Yang, W.C.; Huang, T.P.; Wu, S.C. 1998: Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis Journal of the Formosan Medical Association 97(1): 49-54
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Knudsen, F.; Kristensen, S.D.; Nielsen, A.H.; Ring, T.; Stoffersen, E. 1985: Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction? Clinical Nephrology 23(2): 107
Tilsner, V. 1972: Prophylaxis and therapy of thrombotic diseases with subcutaneous heparin therapy Die Medizinische Welt 23(43): 1553-1556